Today: 14 May 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

This Is Why Loblaw Stock Fell Even as Profit Rose

This Is Why Loblaw Stock Fell Even as Profit Rose

Loblaw missed first-quarter revenue estimates, posting C$14.48 billion versus the expected C$14.55 billion, sending shares down 5%. Net earnings rose to C$594 million, and the company raised its dividend by 10% while approving a new buyback. Discount banners No Frills and Maxi drove growth as shoppers continued to trade down.
6 May 2026
Celsius Stock Near 52-Week Low Before Q1 Earnings as PepsiCo Energy Bet Faces Test

Celsius Stock Near 52-Week Low Before Q1 Earnings as PepsiCo Energy Bet Faces Test

Celsius Holdings shares traded near a 52-week low Wednesday ahead of its first-quarter earnings report, as investors awaited signs of growth from its expanded portfolio with PepsiCo. The company will release results before markets open Thursday. Analysts expect Q1 revenue of $755.2 million, up 129% year-over-year. Celsius now manages CELSIUS, Alani Nu, and Rockstar Energy in the U.S. and Canada.
Beyond Meat Stock Reclaims $1 Before BYND Earnings, But Nasdaq Pressure Remains

Beyond Meat Stock Reclaims $1 Before BYND Earnings, But Nasdaq Pressure Remains

Beyond Meat shares rose above $1 to $1.02 Wednesday ahead of first-quarter earnings, after closing below that level Tuesday. The company faces Nasdaq delisting if its bid price does not stay at or above $1 for 10 straight business days by Aug. 31. Beyond guided Q1 net revenue to $57–$59 million, down from $61.6 million in Q4. U.S. plant-based meat sales remain weak, pressuring the company’s turnaround efforts.
Compass Stock Jumps 26% After Anywhere Deal Fuels Profit, Strong Q2 Outlook

Compass Stock Jumps 26% After Anywhere Deal Fuels Profit, Strong Q2 Outlook

Compass Inc. shares surged 26% after posting a first-quarter profit and forecasting second-quarter revenue above Wall Street estimates. Revenue nearly doubled to $2.70 billion, boosted by the Anywhere Real Estate acquisition. The company reported GAAP net income of $22 million, compared to a $51 million loss a year ago. Compass raised its cost-saving targets and said brokerage transaction value reached $97.3 billion.
Bayer’s $2.45 Billion Perfuse Deal Puts Eye-Drug Pipeline Back in Focus

Bayer’s $2.45 Billion Perfuse Deal Puts Eye-Drug Pipeline Back in Focus

Bayer agreed to acquire Perfuse Therapeutics for up to $2.45 billion, including $300 million upfront, to gain access to a mid-stage eye-disease drug, PER-001. Eylea, Bayer’s top-selling eye drug, saw 2025 sales fall 5.9% to €3.11 billion amid generic competition. The deal awaits antitrust and shareholder approval. PER-001 is in Phase II trials for glaucoma and diabetic retinopathy.
NICE Stock Tumbles After an Earnings Beat. The Guidance Is Why

NICE Stock Tumbles After an Earnings Beat. The Guidance Is Why

NICE Ltd. shares fell 22.9% to $96.35 after the company forecast second-quarter revenue below Wall Street estimates. First-quarter revenue and earnings beat expectations, with cloud revenue up 14.6% and AI annual recurring revenue up 66%. GAAP net income dropped to $46.8 million from $129.3 million a year earlier. NICE cited timing effects from large customer renewals as a factor in the outlook.
NANO Nuclear Stock Jumps as Supermicro AI Data Center Pact Puts Microreactors in Play

NANO Nuclear Stock Jumps as Supermicro AI Data Center Pact Puts Microreactors in Play

NANO Nuclear Energy signed a non-binding MOU with Super Micro Computer to explore using microreactors for powering AI data centers. NANO shares surged 24.6% and Supermicro rose 21.4% after the announcement and a strong outlook. No final contracts or reactor approvals were disclosed. NANO has not reported material revenue and remains in early development.
Why Ernexa Therapeutics Stock Jumped After ERNA-101 Ovarian Cancer Survival Data

Why Ernexa Therapeutics Stock Jumped After ERNA-101 Ovarian Cancer Survival Data

Ernexa Therapeutics said its ERNA-101 cell therapy plus PD-1 blockade cleared tumors and achieved 100% long-term survival in preclinical ovarian cancer models. Shares jumped about 60% after the announcement, trading between $3.70 and $7.66. The company remains preclinical and recently completed a 1-for-25 reverse stock split to maintain its Nasdaq listing.
Dell Technologies Stock Jumps As AI Server Rally And Texas Move Put June Vote In Focus

Dell Technologies Stock Jumps As AI Server Rally And Texas Move Put June Vote In Focus

Dell shares rose about 10% Wednesday, reaching $238.84, as demand for AI servers boosted the stock. The company will ask shareholders to approve moving its legal home from Delaware to Texas at its June 25 annual meeting. Michael Dell and Silver Lake hold enough voting power to influence the outcome. Dell’s market value stood at roughly $158.3 billion in afternoon trading.
CDW Corporation Stock Plunges 20% After Revenue Beat Exposes AI Margin Squeeze

CDW Corporation Stock Plunges 20% After Revenue Beat Exposes AI Margin Squeeze

CDW shares fell 19.5% intraday after first-quarter gross margin dropped to 21.0% from 21.6%, despite net sales rising 9.2% to $5.68 billion. Adjusted earnings of $2.28 per share missed analysts’ estimates by one cent. Investors focused on a shift toward lower-margin hardware sales. The stock traded at $110.11, down $26.69 from Tuesday’s close.
Joby Aviation Stock Jumps 18% After Q1 Earnings as Air Taxi Launch Hopes Take Over

Joby Aviation Stock Jumps 18% After Q1 Earnings as Air Taxi Launch Hopes Take Over

Joby Aviation shares surged 18% after first-quarter revenue beat expectations and the company reiterated plans for initial passenger flights in 2026. Joby ended March with $2.5 billion in cash and short-term investments. Net loss for the quarter was $110 million, with operating expenses at $258 million. FAA certification remains pending before broad commercial service can begin.
Novavax Stock Jumps as Pfizer Vaccine Deal Drives Big Q1 Revenue Beat

Novavax Stock Jumps as Pfizer Vaccine Deal Drives Big Q1 Revenue Beat

Novavax reported first-quarter revenue of $139.5 million, beating estimates as licensing and partner payments, including $30 million from Pfizer, offset weak COVID-19 vaccine sales. Shares rose 15.6% to $9.36 in afternoon trading. Product sales dropped to $42.2 million from $621.7 million a year ago. The company maintained its 2026 adjusted revenue forecast of $230 million to $270 million.
Blue Cross Blue Shield Settlement Payouts Start in May — Who Gets Money From the $2.67 Billion Fund

Blue Cross Blue Shield $2.67 Billion Settlement Payments Are Starting: Who Gets Paid Now

Trader Joe’s will launch Summer Fun Mini Insulated Totes nationwide on May 20 for $3.99 each, with in-store sales only and no online or delivery options. The 1.5-gallon bags come in six summer designs and are expected to sell out quickly, as past releases have drawn long lines and resale markups. The company warns supplies are limited and does not condone reselling.
Primoris Services Corporation Stock Crash: Why PRIM Shares Are Plunging After Q1 Earnings Miss

Primoris Services Corporation Stock Crash: Why PRIM Shares Are Plunging After Q1 Earnings Miss

Primoris Services shares plunged 49% Wednesday after missing Q1 earnings and lowering its 2026 profit outlook, citing cost overruns in renewable-energy projects. The stock traded at $102.54 midday, down $100.38. Q1 net income dropped to $17.4 million from $44.2 million a year earlier. Adjusted earnings of 59 cents a share and revenue of $1.56 billion both fell short of estimates.
Alibaba Stock Jumps as AI Bets Face a May 13 Earnings Test

Alibaba Stock Jumps as AI Bets Face a May 13 Earnings Test

Alibaba’s U.S.-listed shares jumped 6.6% to $141.04 on Wednesday, driven by renewed investor interest in artificial intelligence infrastructure. The rally comes ahead of Alibaba’s March-quarter and fiscal-year earnings report due May 13. Investors are watching for signs that cloud and AI gains can offset weak e-commerce demand. Competitors like DeepSeek are also drawing attention in the AI sector.
Dow Jones Today: 500-Point Rally Puts Blue-Chips Back in Play as Oil Slides and AMD Surges

Dow Jones Today: 500-Point Rally Puts Blue-Chips Back in Play as Oil Slides and AMD Surges

The Dow Jones rose about 500 points Wednesday, reaching 49,795.34 by midday, as falling oil prices and strong AI stock gains lifted Wall Street. Brent crude dipped below $100 after reports of possible U.S.-Iran progress. The S&P 500 and Nasdaq hit record highs. Disney and AMD both reported results above estimates, while U.S. private payrolls posted their largest gain in over a year.
US Stock Market Today: S&P 500 and Nasdaq Hit Records as AMD Rally, Oil Drop Shake Wall Street

US Stock Market Today: S&P 500 and Nasdaq Hit Records as AMD Rally, Oil Drop Shake Wall Street

The S&P 500 and Nasdaq hit record highs Wednesday as AMD shares surged nearly 17% on a strong revenue forecast, boosting AI-linked stocks. The Dow rose 510 points, oil prices dropped nearly 7% on reports of U.S.-Iran progress, and ADP reported 109,000 private-sector jobs added in April. Brent crude fell to $102.24 a barrel.
1 26 27 28 29 30 810

Stock Market Today

  • Why The Trade Desk Stock Is Gaining Investor Attention
    May 14, 2026, 10:32 AM EDT. The Trade Desk (TTD) is drawing investor focus due to its role in helping advertisers maximize the return on ad spending through advanced digital marketing technology. As ad budgets increasingly shift toward programmatic buying - the automated process of purchasing ads online - The Trade Desk's platform has become a key tool for brands aiming to optimize campaign performance and efficiency. Despite modest stock price movement on May 11, 2026, market watchers note growing discussions around the company's prospects amid evolving digital advertising trends. Analyst Parkev Tatevosian, CFA, who holds shares and is affiliated with The Motley Fool, underscores confidence in the firm while acknowledging his financial interests, highlighting the stock's prominence in retail and professional circles.

Latest articles

Quantum Cyber Stock Surges As Drone Deal And Ex-VA Chief Put Defense Pivot In Focus

Quantum Cyber Stock Surges As Drone Deal And Ex-VA Chief Put Defense Pivot In Focus

14 May 2026
Quantum Cyber N.V. appointed former acting U.S. Veterans Affairs Secretary Peter M. O’Rourke Sr. to its board Thursday, a day after announcing an exclusive drone technology license with BP United Inc. Shares surged 264% over the past week, reaching $1.34 premarket. The company, recently renamed from Mainz Biomed, reported a $16.2 million net loss and under $1 million in cash for 2025.
Cisco Stock Surges as AI Orders Boom and Nearly 4,000 Jobs Face Cuts

Cisco Stock Surges as AI Orders Boom and Nearly 4,000 Jobs Face Cuts

14 May 2026
Cisco shares jumped as much as 22% in premarket trading after the company raised its sales forecast and announced a restructuring focused on AI. Cisco reported $15.8 billion in third-quarter revenue and raised its full-year outlook, while planning to cut fewer than 4,000 jobs. The company said it has taken $5.3 billion in AI infrastructure orders from hyperscalers so far in fiscal 2026. Restructuring costs are expected to reach $1 billion before tax.
Forgent Power Stock Jumps After Record Orders Put AI Power Demand Back in Focus

Forgent Power Stock Jumps After Record Orders Put AI Power Demand Back in Focus

14 May 2026
Forgent raised its fiscal 2026 revenue forecast to $1.35 billion–$1.39 billion after third-quarter bookings surged 308% to $867 million, more than double revenue for the period. Backlog reached $1.98 billion at March 31, up 157% from a year earlier. Net income rose to $24.5 million from $8.4 million. Shares climbed $2.51 to $45.52 in premarket trading.
Go toTop